"OPT Congress was a great conference. I can tell a lot of hard work was involved. The on-demand presentations are great!"
-Bob Wu, Gilead Sciences
"The virtual nature actually helped Q&A sessions to be more inclusive with varied content."
- Paul Manley, Orvieto Consulting
"For anyone who is responsible for discovering and developing oligonucleotide therapeutics, OPT Congress provides unmatched content related to R&D, CMC, Regulatory Affairs, & Business Strategy. Despite the virtual format, the technical sessions were of
top-notch quality & facilitated a lively exchange of ideas. I look forward to attending OPT in person, which I expect to be as enlightening as the virtual event, if not more so."
- Lael Cheung, Bachem Americas Inc
"This virtual event makes me feel connected to the community. It was good to catch up with previous colleagues. People's resilience in difficult times inspired me. Thank you!"
-Xiao Hu, Wave Life Sciences
"It was a very well-managed virtual conference"
-Tara Scherder, SynoloStats
“Well balanced content, perfectly executed logistics.”
-Dmitry Samarsky, PhD, CTO, Sirnaomics
“The scientific quality and value of the presentations was very high. The opportunities for networking were excellent. I very much enjoyed attending the conference.”
-Ekkehard Leberer, PhD, Senior Director, R&D Alliance Management, Sanofi